INTRODUCTION/OBJECTIVE: Dizziness is a very common symptom and its diagnosis should be based on history, clinical assessment, and laboratory tests. The aim of this study was to identify the major signs and symptoms of metabolic and central dizziness, as well as its associated comorbidities and the effectiveness of proposed therapies. MATERIALS AND METHODS, RESULTS, AND DISCUSSION: A retrospective review of medical records of patients with dizziness (central and metabolic) from 2006 to 2009 was performed. It was found that 54.2% of patients were diagnosed with metabolic dizziness (mean age, 59 years) and 45.8% of patients with central dizziness (mean age, 54 years). The most common symptoms in both disorders were vertigo, imbalance, and tinnitus. Metabolic dizziness was associated with hypertension, hypertriglyceridemia, diabetes, and hypothyroidism; while central dizziness appeared as a symptom of vascular diseases, neurological tumors, and as a sequel of head trauma. Both disorders require vestibular rehabilitation, metabolic control, and drug therapy. The most prescribed drug was betahistine, followed by ginkgo biloba. Physiotherapy and neurological evaluation were required for central dizziness. Metabolic dizziness showed better improvement and cure with treatment. CONCLUSION: Metabolic dizziness was more prevalent than central dizziness. The most common symptoms were vertigo, imbalance, and tinnitus. The most prescribed treatments were to control comorbidities, vestibular rehabilitation, and betahistine. The best rate of improvement and cure was found in metabolic dizziness.